MwanzoNBY • NYSEAMERICAN
NovaBay Pharmaceuticals Inc
$ 0.70
Baada ya Saa za Kazi:
$ 0.67
(4.97%)-0.035
Imefungwa: 6 Feb, 18:40:24 GMT -5 · USD · NYSEAMERICAN · Kanusho
HisaHisa zinazouzwa MarekaniMakao yake makuu ni Marekani
Bei iliyotangulia
$ 0.67
Bei za siku
$ 0.65 - $ 0.70
Bei za mwaka
$ 0.36 - $ 9.08
Thamani ya kampuni katika soko
3.42M USD
Wastani wa hisa zilizouzwa
elfu 420.55
Uwiano wa bei na mapato
-
Mgao wa faida
-
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
(USD)Sep 2024Mabadiliko Tangu Mwaka Uliopita
Mapato
2.44M-1.61%
Matumizi ya uendeshaji wa biashara
2.65M12.46%
Mapato halisi
-1.21M31.02%
Kiwango cha faida halisi
-49.6529.89%
Mapato kwa kila hisa
-0.5995.41%
EBITDA
-1.05M-53.58%
Asilimia ya kodi ya mapato
——
Jumla ya mali
Jumla ya dhima
(USD)Sep 2024Mabadiliko Tangu Mwaka Uliopita
Uwekezaji wa pesa taslimu na vipindi vifupi
elfu 776.00-77.65%
Jumla ya mali
3.88M-69.83%
Jumla ya dhima
2.80M-51.76%
Jumla ya hisa
1.07M—
hisa zilizosalia
4.89M—
Uwiano wa bei na thamani
3.06—
Faida inayotokana na mali
-68.00%—
Faida inayotokana mtaji
-142.34%—
Mabadiliko halisi ya pesa taslimu
(USD)Sep 2024Mabadiliko Tangu Mwaka Uliopita
Mapato halisi
-1.21M31.02%
Pesa kutokana na shughuli
-2.06M-466.21%
Pesa kutokana na uwekezaji
elfu -2.00-100.00%
Pesa kutokana na ufadhili
2.09M462.05%
Mabadiliko halisi ya pesa taslimu
elfu 26.00102.13%
Mtiririko huru wa pesa
-1.48M-433.66%
Kuhusu
NovaBay Pharmaceuticals, Inc. is an Emeryville, California based clinical-stage biopharmaceutical company, focused on developing novel, fast-acting, synthetic anti-infectives compounds. These compounds are designed to mimic the body's defense system against infection. The company is currently focused on products for the eye care market. Major products include Avenova, cleared by FDA for lid and lash cleansing as part of a regimen for Blepharitis. and NeutroPhase, used in treatment of Necrotizing Fasciitis Wikipedia
Ilianzishwa
2000
Wafanyakazi
25
Tafuta
Futa utafutaji
Funga kisanduku cha kutafutia
Programu za Google
Menyu kuu